Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19
A Promising Response to the Global Unprecedented Pandemic
- 1st Edition - November 8, 2024
- Latest edition
- Editors: Nabeelah Bibi Sadeer, Thomas Efferth
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 7 5 7 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 7 5 8 - 2
Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19: A Promising Response to the Global Unprecedented Pandemic presents comprehen… Read more
Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19: A Promising Response to the Global Unprecedented Pandemic presents comprehensive coverage of the pharmacological effects of natural products on the prevention and treatment of COVID-19. Sections provide traditional medicine approaches and their potential to prevent and treat COVID-19 infection, including traditional Chinese, Ayurvedic, Persian, and Kampo medicine, alongside an overview of nutritional regimens and their therapeutic potential. Other sections cover natural molecules such as flavonoids, saponins, coumarins, alkaloids, terpenes, polysaccharides, and several microbial natural products of relevant action against viruses. Final chapters cover nanotherapeutic approaches.
This is a valuable resource for researchers and academics in the fields of herbal medicine, pharmacology, pharmacognosy and for professionals in the pharmaceutical industries and anyone interested in natural products and their application for therapeutic purposes.
- Provides a complete overview of how natural products can be used to prevent and combat the COVID-19 virus and its associated complications
- Discusses the full extent of what is known to date and provides a thorough view on how herbal medicine can tackle illnesses caused by the COVID-19 pandemic
- Presents insights that healthcare and herbal medicine professionals need to prevent, diagnose and treat COVID-19
Graduate students in pharmacology and Pharmacognosy, Respiratory therapists, Virologists, Pathologists
PART I: Traditional herbal medicines
1. Traditional medicines and natural products for COVID-19: Potential and limitations
2. Chinese herbal medicines for the treatment of COVID-19
3. Traditional Persian medicine as a holistic therapeutic approach to managing COVID-19
4. Functional foods and food components for the management and prevention of COVID-19
5. The potential of ketogenic dietary therapy in the COVID-19 pandemic
6. Flavonoids as potential inhibitors targeting SARS-CoV-2
7. Saponins as potential inhibitors targeting SARS-CoV-2
PART II: Natural products and Natural product-based new medicinal products
8. Coumarins as potential inhibitors targeting SARS-CoV-2
9. Alkaloids as potential inhibitors targeting SARS-CoV-2
10. Terpenes and terpenoids as potential inhibitors targeting SARS-CoV-2
11. Polysaccharides as potential inhibitors targeting SARS-CoV-2
12. Evaluating microbial products as potential SARS-CoV-2 inhibitors
13. Towards natural polymers and nanoparticles as nanotherapies to combat COVID-19
14. Natural products from mushrooms as versatile therapeutic and preventive inhibitors to COVID-19
- Edition: 1
- Latest edition
- Published: November 8, 2024
- Language: English
NS
Nabeelah Bibi Sadeer
Dr. Nabeelah Bibi Sadeer received her PhD in medicinal and pharmaceutical chemistry at the University of Mauritius (Mauritius), MSc degree in forensic science at Staffordshire University (UK), and BSc degree in chemistry at the University of Mauritius (Mauritius). Her PhD research was focused on the phytochemical analysis and pharmacological properties of mangrove plants and their associated fungal endophytes. Nabeelah has authored and coauthored more than 45 publications in high impact factor journals and in prestigious books with several other articles and book chapters under preparation or review. Nabeelah published her first authored book entitled “Mangroves with Therapeutic Potential for Human Health” with Elsevier in 2022.
Affiliations and expertise
Research and Planning Division, Higher Education Commission, Reduit 80835, MauritiusTE
Thomas Efferth
Thomas Efferth is the chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany. He is a biologist by training (Technical University of Darmstadt, Germany). Doctoral thesis: German Cancer Research Center (DKFZ), Heidelberg, Germany (1990). He obtained 9 national and international awards. He is honorary professor at several
international universities. In 2022, he was visiting professor (“professional visitor”) at the McLean Hospital, Harvard Medical School, Boston, USA. Thomas is ordinary member of the Academia Europaea (London). He has 850+ PubMed-listed high impact papers with an h-index of 116 and more than 69,000 citations.
Affiliations and expertise
Chair of Department, Institute of Pharmaceutical and Biomedical Sciences, Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, GermanyRead Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19 on ScienceDirect